AUSTIN, Texas, March 13 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. , a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases, will hold its quarterly conference call to discuss fourth quarter results on Wednesday, March 15, 2006, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time).
This call is being webcast by Thomson/CCBN and can be accessed at Introgen's Web site at http://www.introgen.com .
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com , Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com ), a password-protected event management site.
About Introgen Therapeutics, Inc.
Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.
Introgen Therapeutics, Inc.CONTACT: Channing Burke of Introgen Therapeutics, Inc., +1-512-708-9310ext 322, or c.burke@introgen.com
